Skip to content
Chat on WhatsApp
CagriSema

Incretin-Pathway Peptides

CagriSema

A two-component blend of cagrilintide and semaglutide, sealed as a lyophilized vial for comparative signaling research.

  • Cagrilintide and semaglutide combined
  • Composition set out in batch documentation
  • Sealed vials, 5mg to 20mg total

Research use only

CagriSema combines the amylin analogue cagrilintide with the GLP-1 analogue semaglutide in a single lyophilized vial. As a two-peptide blend, this entry does not carry a single CAS number or molecular weight; the composition for a given batch is described in that batch's documentation.

This combination is referenced in controlled in-vitro research for comparative signaling studies across the two component pathways, and for analytical work assessing how the two peptides behave when prepared together.

The vial is sealed after freeze-drying and offered at the total nominal masses listed under available sizes, from 5mg through 20mg.

Purity≥99% by HPLC
CAS numberSee batch documentation
Molecular weightSee batch documentation
Molecular formulaSee batch documentation
Material classTwo-component peptide blend
AppearanceWhite to off-white lyophilized powder
Available vial sizes5mg total · 10mg total · 20mg total
DocumentationBatch documentation confirmed on request

← Back to the catalog